Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review

BACKGROUND: Neuroimaging-biomarkers of Mild Cognitive Impairment (MCI) allow an early diagnosis in preclinical stages of Alzheimer’s disease (AD). The goal in this paper was to review of biomarkers for Mild Cognitive Impairment (MCI) and Alzheimer’s disease (AD), with emphasis on neuroimaging biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Qingwei, D’Onofrio, Grazia, Sancarlo, Daniele, Bao, Zhijun, Greco, Antonio, Yu, Zhuowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869390/
https://www.ncbi.nlm.nih.gov/pubmed/27184250
http://dx.doi.org/10.1186/s12877-016-0281-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869390/
https://www.ncbi.nlm.nih.gov/pubmed/27184250
http://dx.doi.org/10.1186/s12877-016-0281-7

Ejemplares similares